Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.51 USD | -.--% | -.--% | -.--% |
04-03 | Truist Securities Trims Price Target on American Healthcare REIT to $16 From $17, Maintains Buy Rating | MT |
03-22 | Transcript : American Healthcare REIT, Inc., Q4 2023 Earnings Call, Mar 22, 2024 |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- Low profitability weakens the company.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Ratings chart - Surperformance
Sector: Specialized REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 1.64B | - | - | |
+9.60% | 59.09B | A- | ||
-4.57% | 19.25B | A- | ||
-1.26% | 13.76B | A | ||
+0.10% | 7.58B | B | ||
-10.80% | 5.82B | B- | ||
+10.32% | 3.51B | C- | ||
+1.82% | 3.36B | C+ | ||
-1.26% | 3.22B | B+ | ||
+16.92% | 2.84B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- AHR Stock
- GRAH Stock
- Ratings American Healthcare REIT, Inc.